C. Manegold

Phase III Trial of Gemcitabine Plus Cisplatin Versus Cisplatin Alone in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer

Alan B. Sandler, John Nemunaitis, Claude Denham et al. · Journal of Clinical Oncology · 2000 · 718 citations

Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy.

Martin Pecherstorfer, Z. Herrmann, Jean‐Jacques Body et al. · Journal of Clinical Oncology · 1996 · 127 citations

Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: An EORTC double-blind placebo-controlled phase III study

Vivianne C. G. Tjan‐Heijnen, Pieter E. Postmus, Andrea Ardizzoni et al. · Annals of Oncology · 2001 · 113 citations

Antibiotics, Medicine, Metronomic Therapy +10

Vandetanib versus placebo in patients with advanced non-small cell lung cancer (NSCLC) after prior therapy with an EGFR tyrosine kinase inhibitor (TKI): A randomized, double-blind phase III trial (ZEPHYR).

J. Lee, Vera Hirsh, K. Park et al. · Journal of Clinical Oncology · 2010 · 52 citations

Vandetanib Versus Placebo, Advanced Nsclc, Prior Therapy +15

Serum Parathyroid Hormone-Related Protein Levels and Response to Bisphosphonate Treatment in Hypercalcemia of Malignancy

R. Rizzoli, D. Thiébaud, Nigel Bundred et al. · The Journal of Clinical Endocrinology & Metabolism · 1999 · 47 citations · Full text